Literature DB >> 12482991

betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.

Valerie Lang1, Julia Janzen, Gregory Zvi Fischer, Yasmina Soneji, Sören Beinke, Andres Salmeron, Hamish Allen, Ronald T Hay, Yinon Ben-Neriah, Steven C Ley.   

Abstract

NF-kappaB1 p105 functions both as a precursor of NF-kappaB1 p50 and as a cytoplasmic inhibitor of NF-kappaB. Following the stimulation of cells with tumor necrosis factor alpha (TNF-alpha), the IkappaB kinase (IKK) complex rapidly phosphorylates NF-kappaB1 p105 on serine 927 in the PEST region. This phosphorylation is essential for TNF-alpha to trigger p105 degradation, which releases the associated Rel/NF-kappaB subunits to translocate into the nucleus and regulate target gene transcription. Serine 927 resides in a conserved motif (Asp-Ser(927)-Gly-Val-Glu-Thr-Ser(932)) homologous to the IKK target sequence in IkappaBalpha. In this study, TNF-alpha-induced p105 proteolysis was revealed to additionally require the phosphorylation of serine 932. Experiments with IKK1(-/-) and IKK2(-/-) double knockout embryonic fibroblasts demonstrate that the IKK complex is essential for TNF-alpha to stimulate phosphorylation on p105 serines 927 and 932. Furthermore, purified IKK1 and IKK2 can each phosphorylate a glutathione S-transferase-p105(758-967) fusion protein on both regulatory serines in vitro. IKK-mediated p105 phosphorylation generates a binding site for betaTrCP, the receptor subunit of an SCF-type ubiquitin E3 ligase, and depletion of betaTrCP by RNA interference blocks TNF-alpha-induced p105 ubiquitination and proteolysis. Phosphopeptide competition experiments indicate that betaTrCP binds p105 more effectively when both serines 927 and 932 are phosphorylated. Interestingly, however, betaTrCP affinity for the IKK-phosphorylated sequence on p105 is substantially lower than that on IkappaBalpha. Thus, it appears that reduced p105 recruitment of betaTrCP and subsequent ubiquitination may contribute to delayed p105 proteolysis after TNF-alpha stimulation relative to that for IkappaBalpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482991      PMCID: PMC140687          DOI: 10.1128/MCB.23.1.402-413.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  26 in total

1.  The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense.

Authors:  L A O'Neill; C A Dinarello
Journal:  Immunol Today       Date:  2000-05

Review 2.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

Review 3.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  Homodimer of two F-box proteins betaTrCP1 or betaTrCP2 binds to IkappaBalpha for signal-dependent ubiquitination.

Authors:  H Suzuki; T Chiba; T Suzuki; T Fujita; T Ikenoue; M Omata; K Furuichi; H Shikama; K Tanaka
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

Review 5.  Tumor necrosis factor receptor and Fas signaling mechanisms.

Authors:  D Wallach; E E Varfolomeev; N L Malinin; Y V Goltsev; A V Kovalenko; M P Boldin
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

6.  NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.

Authors:  V Heissmeyer; D Krappmann; F G Wulczyn; C Scheidereit
Journal:  EMBO J       Date:  1999-09-01       Impact factor: 11.598

7.  Phosphorylation of p105 PEST sequence via a redox-insensitive pathway up-regulates processing of p50 NF-kappaB.

Authors:  M L MacKichan; F Logeat; A Israël
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

8.  Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.

Authors:  A Yaron; A Hatzubai; M Davis; I Lavon; S Amit; A M Manning; J S Andersen; M Mann; F Mercurio; Y Ben-Neriah
Journal:  Nature       Date:  1998-12-10       Impact factor: 49.962

9.  TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.

Authors:  M P Belich; A Salmerón; L H Johnston; S C Ley
Journal:  Nature       Date:  1999-01-28       Impact factor: 49.962

10.  Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50.

Authors:  H Ishikawa; E Claudio; D Dambach; C Raventós-Suárez; C Ryan; R Bravo
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

View more
  60 in total

Review 1.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

2.  Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation.

Authors:  Christophe Butticaz; Olivier Michielin; Josiane Wyniger; Amalio Telenti; Sylvia Rothenberger
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

3.  Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination.

Authors:  Hui Geng; Tobias Wittwer; Oliver Dittrich-Breiholz; Michael Kracht; Michael Lienhard Schmitz
Journal:  EMBO Rep       Date:  2009-03-06       Impact factor: 8.807

4.  Functional regulation of the epithelial Na+ channel by IkappaB kinase-beta occurs via phosphorylation of the ubiquitin ligase Nedd4-2.

Authors:  Robert S Edinger; Jonathan Lebowitz; Hui Li; Rodrigo Alzamora; Huamin Wang; John P Johnson; Kenneth R Hallows
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

Review 5.  Specification of DNA binding activity of NF-kappaB proteins.

Authors:  Fengyi Wan; Michael J Lenardo
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

6.  G-protein-coupled-receptor kinases mediate TNFα-induced NFκB signalling via direct interaction with and phosphorylation of IκBα.

Authors:  Sonika Patial; Jiansong Luo; Katie J Porter; Jeffrey L Benovic; Narayanan Parameswaran
Journal:  Biochem J       Date:  2009-12-14       Impact factor: 3.857

7.  Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.

Authors:  S Beinke; M J Robinson; M Hugunin; S C Ley
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  Directed expression of the HIV-1 accessory protein Vpu in Drosophila fat-body cells inhibits Toll-dependent immune responses.

Authors:  François Leulier; Christelle Marchal; Isabelle Miletich; Bernadette Limbourg-Bouchon; Richard Benarous; Bruno Lemaitre
Journal:  EMBO Rep       Date:  2003-09-12       Impact factor: 8.807

9.  NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.

Authors:  S Beinke; J Deka; V Lang; M P Belich; P A Walker; S Howell; S J Smerdon; S J Gamblin; S C Ley
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

Review 10.  The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target.

Authors:  Yonghui Yu; Yu Wan; Chuanshu Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.